GlassScriptPhysician profile
Arieal M Mitchell
NPI 1356801765
$2,391.55
in general payments reported to CMS, 2019-2025
18 companies · $82.90 in 2025
The $82.90 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,000 · 2022: $964 · 2023: $98.08 · 2024: $247 · 2025: $82.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.14 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $309.56 | 2021-2024 | |
| Gilead Sciences, INC. | $222.20 | 2021-2024 | |
| Stemline Therapeutics INC. | $155.20 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Pharmacosmos Therapeutics INC. | $122.10 | 2022 | |
| Puma Biotechnology, INC. | $121.83 | 2021 | |
| Amgen INC. | $116.82 | 2021 | |
| Myovant Sciences INC. | $116.42 | 2021 | |
| Daiichi Sankyo INC. | $115.57 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $105.86 | 2022 | |
| Pharmaessentia USA Corporation | $103.16 | 2022 | |
| Apellis Pharmaceuticals, INC. | $100.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $95.32 | 2022 | |
| Celgene Corporation | $89.15 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $87.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.34 | 2025 | |
| Boston Scientific Corporation | $15.56 | 2025 | Ekosonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arieal Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.